IBI-Ag
Bioinsecticides for a Sustainable Food Supply
Company Overview
Snapshot
Founded in March 2017 by Rony Oren Benaroya and Amir Ayali, IBI-Ag operates with 11–50 employees. The company has raised $11.64M across 7 funding rounds from 9 investors. In November 2025, IBI-Ag completed a Series A round led by Corteva.
Business overview
IBI-Ag is an Agriculture & Food Technologies company focused on developing biological solutions for insect control. The company utilizes breakthrough technology to produce efficient, selective, and safe bio-insecticides, enabling farmers to produce agricultural produce at a lower cost. IBI-Ag serves the agriculture industry, operating within the Ag Tech and Sustainable Farming sectors.
Strategic signal
In November 2025, IBI-Ag completed a Series A funding round led by Corteva. This investment signals strong market validation for IBI-Ag's bio-insecticide technology and its potential to redefine sustainable agriculture by offering environmentally friendly and cost-effective pest control solutions. For investors, this indicates a significant step towards commercialization and market penetration in the agricultural sector.
Company Intelligence Q&A
- When was IBI-Ag founded?
- IBI-Ag was founded in March 2017.
- Who are the founders of IBI-Ag?
- The co-founders of IBI-Ag are Rony Oren Benaroya and Amir Ayali.
- What was a significant recent funding event for IBI-Ag?
- In November 2025, IBI-Ag completed a $10 million Series A funding round led by Corteva.
- What is IBI-Ag's core technology?
- IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe biological insect-control solutions, focusing on single-domain antibody technology.
- Which investors participated in IBI-Ag's November 2025 funding round?
- Corteva led the November 2025 funding round, with participation from The Trendlines Group.